|
× |
 |
Depression-Free Days as a Summary Measure of the Temporal Pattern of Response and Remission in the Treatment of Major Depression: A Comparison of Venlafaxine, Selective Serotonin Reuptake Inhibitors, and Placebo PDF |
$40.00 |
|
$40.00 |
|
× |
|
Differential Prediction of First Clinical Response to Serotonergic and Noradrenergic Antidepressants Using the Loudness Dependence of Auditory Evoked Potentials in Patients With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Reduced Suicidal Ideation in Bipolar I Disorder Mixed-Episode Patients in a Placebo-Controlled Trial of Olanzapine Combined With Lithium or Divalproex. PDF |
$40.00 |
|
$40.00 |
|
× |
|
Comorbidity of DSM-IV Pathological Gambling and Other Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. PDF |
$40.00 |
|
$40.00 |
|
× |
|
Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Naturalistic Study of the Association Between Antidepressant Treatment and Outcome of Smoking Cessation Treatment PDF |
$40.00 |
|
$40.00 |
|
× |
|
Toxic Effects of Psychotropics Related to Possible P450 Enzyme Inhibition by Kava: Report of 2 Cases PDF |
$40.00 |
|
$40.00 |
|
|
